A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Clostridoides Difficile Infe⦠(NCT04100603) | Clinical Trial Compass
WithdrawnNot Applicable
A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Clostridoides Difficile Infection
Stopped: Company focus shifted
United States0Started 2020-03-02
Plain-language summary
This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records.
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Willingness to sign informed consent
* Diagnosis of C. difficile infection
* Age of 18 and older
Exclusion Criteria:
* Refusal by patient to sign informed consent form
* Treatment with antibiotics 2 weeks prior to screening
* Treatment with probiotics 6 weeks prior to screening
* History of bariatric surgery, total colectomy with ileorectal anastomosis or proctocolectomy.
* Postoperative stoma, ostomy, or ileoanal pouch
* Participation in any experimental drug protocol within the past 12 weeks
* Treatment with total parenteral nutrition
* Any clinically significant evidence of disease that could interfere with the subject's ability to enter the trial
* Inability of patient to adequately communicate with the investigator or their respective designee and/or comply with the requirements of the entire study
What they're measuring
1
Correlation of Microbiome to Disease via Relative Abundance Found in Microbiome Sequencing